Sisomicin

Jump to: navigation, search
Sisomicin
Sisomicin.png
Clinical data
Trade namesbactoCeaze
AHFS/Drugs.comInternational Drug Names
Routes of
administration
topical
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
PubChem CID
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H37N5O7
Molar mass447.53 g/mol
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Sisomicin

Articles

Most recent articles on Sisomicin

Most cited articles on Sisomicin

Review articles on Sisomicin

Articles on Sisomicin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sisomicin

Images of Sisomicin

Photos of Sisomicin

Podcasts & MP3s on Sisomicin

Videos on Sisomicin

Evidence Based Medicine

Cochrane Collaboration on Sisomicin

Bandolier on Sisomicin

TRIP on Sisomicin

Clinical Trials

Ongoing Trials on Sisomicin at Clinical Trials.gov

Trial results on Sisomicin

Clinical Trials on Sisomicin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sisomicin

NICE Guidance on Sisomicin

NHS PRODIGY Guidance

FDA on Sisomicin

CDC on Sisomicin

Books

Books on Sisomicin

News

Sisomicin in the news

Be alerted to news on Sisomicin

News trends on Sisomicin

Commentary

Blogs on Sisomicin

Definitions

Definitions of Sisomicin

Patient Resources / Community

Patient resources on Sisomicin

Discussion groups on Sisomicin

Patient Handouts on Sisomicin

Directions to Hospitals Treating Sisomicin

Risk calculators and risk factors for Sisomicin

Healthcare Provider Resources

Symptoms of Sisomicin

Causes & Risk Factors for Sisomicin

Diagnostic studies for Sisomicin

Treatment of Sisomicin

Continuing Medical Education (CME)

CME Programs on Sisomicin

International

Sisomicin en Espanol

Sisomicin en Francais

Business

Sisomicin in the Marketplace

Patents on Sisomicin

Experimental / Informatics

List of terms related to Sisomicin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Sisomicin (bactoCeaze or Ensamycin) is an aminoglycoside antibiotic, isolated from the fermentation broth of a new species of the genus Micromonospora.[1] It is a newer broad-spectrum aminoglycoside most structurally related to gentamicin.

Sisomicin is the most predictably active aminoglycoside against gram-positive bacteria.[2] Like most other aminoglycosides, Sisomicin is bactericidal for sensitive clinical isolates. The minimum bactericidal concentrations (MBC) have been found to be equivalent or very close to the minimum inhibitory concentrations (MIC).[2] Like other aminoglycosides, most clinical isolates of Pseudomonas aeruginosa remain susceptible to sisomicin. Resistance to sisomicin may enzymatically or non-enzymatically be mediated. Sisomicin is inactivated by the same enzymes as gentamicin but it is active against many, not all, organisms that resist gentamicin by non-enzymatic mechanisms.[3]

Some studies show that sisomicin has been effective in the treatment of infections that either had failed to respond to other drugs or were due to microorganisms resistant in vitro to other aminoglycosides.[4][5]

References

  1. M. J. Weinstein, J. A. Marquez, R. T. Testa, G. H. Wagman, E. M. Oden, J. A. Waitz (Nov 1970). "Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic". J. Antibiot. 23 (11): 551–554. doi:10.7164/antibiotics.23.551. PMID 5487129.
  2. 2.0 2.1 WE Sanders Jr, CC Sanders. (Mar–Apr 1980). "Sisomicin: a review of eight years' experience". Rev Infect Dis. 2 (2): 182–195. doi:10.1093/clinids/2.2.182. PMID 6994206.
  3. I Phillips, BA King, KP Shannon. (Mar 1978). "The mechanisms of resistance to aminoglycosides in the genus Pseudomonas". J Antimicrob Chemother. 4 (2): 121–129. doi:10.1093/jac/4.2.121. PMID 649532.
  4. ME Levison, D Kaye. (Mar 1979). "A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies". Medicine (Baltimore). 58 (2): 159–170. doi:10.1097/00005792-197903000-00004. PMID 431401.
  5. DG Maki, WA Craig, WA Agger. (Jun 1979). "A comparative clinical trial of sisomicin and gentamicin in major gram-negative infections". Infection 7(Suppl. 3). 5 (6): 298–300. doi:10.1007/bf01646260.

Linked-in.jpg